Anti-CD10 MME Monoclonal Antibody

Overview

This product is an anti-MME antibody for target detection and characterization. Key identifiers include host species: Rabbit; Monoclonal; clone AFGB-13; isotype Rabbit IgG; reactivity: Human,Rat. Reported application contexts include WB, IHC, IP (as provided in the source record). Boster Bio Anti-CD10 MME Monoclonal Antibody catalog # M04065-1. Tested in WB, IHC, IP applications. This antibody reacts with Human, Rat.

Key elements and design rationale

• Target: MME (Neprilysin).
• Antibody format: Monoclonal; clone AFGB-13; isotype Rabbit IgG.
• Host: Rabbit.
• Species reactivity: Human,Rat (confirm in your model system with appropriate controls).

This description is intended to help interpret the antibody design and the biological context of the target using the fields provided in the catalog record, alongside general experimental considerations.

Biological background

MME (protein: T-cell surface glycoprotein CD3 zeta chain) is a commonly studied target in molecular and cellular biology. Functional context (as provided): Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids (PubMed:15283675, PubMed:8168535). Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond (PubMed:17101991). Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9 (PubMed:15283675). Involved in the degradation of atrial natriuretic factor (ANF) (PubMed:2531377, PubMed:2972276). Displays UV-inducible elastase activity toward skin preelastic and elastic fibers (PubMed:20876573). . Reported cellular localization context: Cell membrane; Single-pass type II membrane protein. Tissue expression notes (as provided): Mainly expressed in endothelial cells lining lymphatic vessels. .

Research relevance and current trends

• Research context keywords from the source record include: Angiogenesis,Atherosclerosis,Cancer,Cardiovascular,Cytoskeleton/ECM,ECM Enzymes,Extracellular Matrix,Invasion/Microenvironment,Signal Transduction,Tumor Biomarkers.
• Current studies often focus on connecting target abundance/localization to pathway perturbations across models, tissues, and cell states.
• Quantitative and multiplexed assays (e.g., imaging + immunoblot panels) are commonly used to compare phenotypes across conditions and time-courses.

Common research applications

• Western blotting (WB): assess relative target abundance across samples, treatments, or time-points.
• Immunohistochemistry (IHC): evaluate spatial distribution of target-positive staining in tissue architecture.
• Immunoprecipitation (IP): enrich target complexes for downstream immunoblot or interaction analyses.

Workflow ideas (metafield): Validate MME antibody specificity using KO/KD control samples (WB/IF/IHC as appropriate), Detect MME expression by Western blot in cell or tissue lysates, Detect MME in FFPE tissue sections by immunohistochemistry, Enrich MME by immunoprecipitation from lysates for downstream analysis

Notes for experimental interpretation

• Consider isoforms and post-translational modifications (PTMs) that may shift apparent molecular weight or epitope accessibility.
• Apparent molecular weight may vary by sample type and processing (observed MW: 37 kDa; calculated MW: 85514 MW).
• Control concepts: include appropriate negative controls (e.g., isotype, KO/KD samples) and orthogonal validation when feasible.

Additional product details (from the source record)

• Molecular weight (observed): 37 kDa
• Cellular localization (provided): Cell membrane; Single-pass type II membrane protein.
• Tissue details (provided): Mainly expressed in endothelial cells lining lymphatic vessels. .

Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.